An interventional study of ViaHabit in Physical Inactivity and Sedentary Lifestlye, sponsored by Louisiana State University and A&M College. Not yet recruiting at 1 site in United States. Open to participants aged 45 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-20.
Sponsored by Louisiana State University and A&M College · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 452 studies in Sedentary Behavior with a site in United States — 61 open to participants now, 89 under way, none of them phase 3. Sedentary Behavior · United States.
Among the 452 studies in Sedentary Behavior with a site in United States, this one is the 382nd largest by planned enrollment of the 421 interventional ones that give a count, is one of 2 that started in 2027, is one of 386 with no phase, reaches primary completion later than 48 of the 88 other live ones, and was the 450th registered.
1,276 studies on the registry are indexed under Sedentary Behavior; 292 are open to participants now.
Browse Sedentary Behavior studies →61 of the 452 studies in Sedentary Behavior with a site in United States are open now. Recruiting first, the newest first:
St. Louis University · Sites in United States
Ages 18–69
University of Pittsburgh · Sites in United States
Ages 14–26
University of Wisconsin, River Falls · Sites in United States
Ages 18–60 · Healthy volunteers
The University of Tennessee, Knoxville · Sites in United States
Ages 65+
San Diego State University · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 184 Sedentary Behavior studies recruiting now, 77 (42%) set no upper age limit and 82 (45%) stop at 75 or younger; 30 take children under 18; 97 take healthy volunteers.
This study: 45 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
452 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 19 · Phase 2 15 · Phase 3 3 · Phase 4 2
First in 2000; this study’s year is marked. 2 started in 2027.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 10 is below the median of 60 across 1,077 interventional studies indexed under Sedentary Behavior.
Median enrollment 60 across the 421 interventional studies, 122 across the 30 observational. Of the 335 that completed or were terminated, 105 (31%) have results posted.
This tab as a report to print or save as PDF → With an account.
9 of 452 have an industry lead sponsor. The 10 most frequent:
Louisiana State University and A&M College is the lead sponsor of 13 studies on the registry; 7 are open to participants now.
Louisiana State University and A&M College has 1 study filed under Sedentary Behavior — fewer than ten, so there is no comparison to draw.
40 of the studies in Sedentary Behavior with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07520786University of GeorgiaChanges in 24-hour Activity Cycle Behaviors During a Time-Restricted Eating Intervention in College-Aged Women | 2026-11 |
| NCT06923397Dana-Farber Cancer InstituteInterrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND Trial | 2026-11-28 |
| NCT06116435University of Colorado, DenverA Pilot Factorial Trial of an Integrated Lifestyle Intervention | 2026-12 |
| NCT06754280University of Illinois at ChicagoAn Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease | 2026-12 |
| NCT07270016University of PittsburghPilot-Testing Real-Time Engagement for Learning to Effectively Control Type 2 Diabetes | 2026-12 |
Add all 40 to your calendar (.ics) → With an account.
Among the 452 studies in Sedentary Behavior with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This pilot study will develop and evaluate ViaHabit, a personalized walking intervention designed to promote physical activity habit formation among sedentary midlife adults (ages 45-65). During an initial 2-week observation period, participants' daily routines will be characterized using data collected from wearable devices, smartphones, and digital calendars. Personalized models will identify routine transitions, defined as periods between everyday activities, that may serve as receptive opportunities for initiating physical activity. Participants will then complete a 4-week intervention in which they create individualized "if-then" action plans linking routine transitions to a 15-minute brisk walk and receive automated smartwatch prompts at selected cue times. The study will assess the feasibility and acceptability of identifying routine transitions and delivering timely physical activity prompts, while exploring changes in walking behavior, habit strength, and physical activity engagement.
This pilot study will develop and evaluate ViaHabit, a personalized, cue-based walking intervention designed to promote physical activity habit formation among sedentary midlife adults. The study is based on the premise that routine transitions, defined as periods when one daily activity has ended and another has not yet begun, may represent receptive opportunities for initiating new health behaviors. The long-term goal is to increase physical activity during midlife, a critical period for reducing risk factors associated with cognitive decline and dementia.
The study will enroll approximately 10 adults aged 45 to 65 years who are physically inactive and experience competing work, caregiving, parenting, or other role demands. Participants must own or be willing to use an iPhone-compatible device and be able to walk without assistance.
The study uses a 12-week, single-arm, within-subject design consisting of two phases. During Phase 1 (2-week observation period), participants will use an Apple Watch, smartphone applications, and digital calendar tools to collect multimodal data on daily behavior, including physical activity, location patterns, calendar events, and contextual information. These data will be used to develop individualized computational models of participants' daily routines and identify recurring routine transitions that may serve as effective cues for physical activity initiation.
Following model development, participants will enter Phase 2 (4-week intervention period). In a virtual coaching session, participants will identify up to two routine transitions that can function as cues for walking and will create personalized "if-then" action plans linking those cues to a 15-minute brisk walk. Automated smartwatch notifications will be delivered when the selected routine transitions occur to increase cue salience and support initiation of physical activity. Walking behavior will be continuously monitored through wearable devices.
The primary objectives are to evaluate the feasibility of identifying individualized routine transitions from passive sensing data and the feasibility and acceptability of delivering a personalized, cue-based walking intervention anchored to those transitions. Secondary and exploratory outcomes include adherence to study procedures, walking behavior, cue-triggered behavioral enactment, habit strength, physical activity levels, and cognitive function. Habit strength will be assessed using measures of behavioral automaticity, while cognitive function will be evaluated through mobile cognitive assessments administered during the intervention period.
The findings will inform the development of scalable, data-driven interventions that leverage naturally occurring daily routines to support physical activity habit formation and healthy aging.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants complete a 2-week observation period during which individualized routine models are developed using wearable, smartphone, and calendar data, followed by a 4-week ViaHabit intervention consisting of routine-transition cue selection, if-then action planning, and automated smartwatch prompts to support initiation of 15-minute brisk walks.
Behavioral: ViaHabit
ViaHabit is a personalized, cue-based walking intervention designed to promote physical activity habit formation in sedentary midlife adults. Following a 2-week observation period, individualized routine models are developed using data collected from wearable devices, smartphones, and digital calendars. Participants then complete a coaching session to identify up to two routine transitions that can serve as cues for physical activity and develop personalized if-then action plans linking each cue to a 15-minute brisk walk. During the 4-week intervention period, automated smartwatch notifications are delivered at the selected routine-transition cues to increase cue salience and support initiation of walking behavior. The intervention aims to strengthen cue-behavior associations through repeated pairing of routine completion cues with walking, thereby increasing behavioral automaticity and physical activity participation.
Feasibliity of the ViaHabit Intervention - Recruitment
Feasibility will be assessed by participant recruitment rates.
Time frame: Week 8 (end of intervention)
Feasibliity of the ViaHabit Intervention - Retention
Feasibility will be assessed by participant retention rates.
Time frame: Week 8 (end of intervention)
Feasibliity of the ViaHabit Intervention - Data Collection
Feasibility will be assessed by participant completion of Phase 1 data collection.
Time frame: Week 8 (end of intervention)
Habit Strength for Walking
Habit strength will be assessed using the 4-item Self-Reported Behavioral Automaticity Index (SRBAI), adapted to each participant's selected routine-transition cue. Higher scores indicate greater automaticity of walking behavior in response to the cue.
Time frame: Baseline and weekly during the 4 week intervention period through Week 8
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Jan 2027; primary completion for May 2027, 4 months later.
Of 736 non-industry interventional studies with no phase under Sedentary Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 30. This study's planned 4 months is below that.
Counting every sponsor, half of 744 studies reached it within 14 months; a quarter within 6 and three quarters within 30.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 20, 2026: start Oct 2026 → Jan 2027 and primary completion Apr 2027 → May 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Louisiana State University and A&M College